|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0274 | ED149668 | General Research Use | No | Female | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0294 | ED148943 | General Research Use | No | Female | White | 55 | 8 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0506 | ED149124 | General Research Use | No | Male | White | 74 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1298 | ED149790 | General Research Use | No | Female | White | 65 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2119 | ED149373 | General Research Use | No | Female | White | 67 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2507 | ED149862 | General Research Use | No | Male | White | 76 | 8 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3269 | ED149318 | General Research Use | No | Female | White | 80 | 8 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_3433 | ED149558 | General Research Use | No | Male | White | 66 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0642 | ED148713 | General Research Use | No | Male | White | 61 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1644 | ED149741 | General Research Use | No | Female | White | 70 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2001 | ED148120 | General Research Use | No | Female | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3559 | ED149605 | General Research Use | No | Female | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3857 | ED149964 | General Research Use | No | Male | White | 70 | 8 - AREDS AMD Severity Scale Step 5 | 10 - Central GA |
| AR2_4129 | ED149967 | General Research Use | No | Male | White | 72 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0134 | ED148484 | General Research Use | No | Female | White | 63 | 8 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1343 | ED149369 | General Research Use | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2613 | ED149409 | General Research Use | No | Female | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3768 | ED149282 | General Research Use | No | Male | White | 59 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3769 | ED148317 | General Research Use | No | Male | White | 71 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3990 | ED149631 | General Research Use | No | Female | White | 66 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |